About Kasper Roet
Form D filings for EnClear Therapies in 2024 list Kasper Roet as director.
Kasper Roet first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Kasper Roet in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kasper Roet works with at each company, as listed on that company's latest Form D.
EnClear Therapies, Inc. · Form D, Mar 1, 2024
